# Compassionate Use Ponatinib

> **NCT01549548** · — · NO_LONGER_AVAILABLE · sponsor: **OHSU Knight Cancer Institute**

## Conditions studied

- Philadelphia Chromosome Positive (Ph+) Leukemias
- Chronic Myeloid Leukemia

## Interventions

- **DRUG:** Ponatinib

## Key facts

- **NCT ID:** NCT01549548
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01549548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01549548, "Compassionate Use Ponatinib". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01549548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*